AMBER DEAN: Open Payments
NPI 1023859220 · SEDALIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $363 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $93 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| GENZYME CORPORATION | 1 | $25 |
| PFIZER INC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: LEQVIO, VERQUVO, FABRAZYME, ENTRESTO, ELIQUIS, JARDIANCE, SHINGRIX.
Industry payments across MO — which companies pay providers there.
